Trial intelligence / Profile preview

Efficacy of donepezil in treatment of acute ischemic stroke complications

IRCT20220430054710N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of donepezil in ischemic stroke, sponsored by Iran University of Medical Sciences. Started Jul 2022; status: completed.

02

Drugs

donepezil
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on IRCT20220430054710N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220430054710N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call